Wegovy is the first GLP-1 drug approved to treat adults with metabolic dysfunction-associated steatohepatitis (MASH). An ...

Joshua Fredell, Pharm.D., senior vice president at CVS Caremark, says innovation in PBMs comes from simplifying pricing, offering flexible benefit designs, and using technology to create a smoother ...

An expert discusses how non-muscle invasive bladder cancer (NMIBC) creates a significant clinical and financial burden with up to 60% recurrence rates, affecting an estimated 85,000 new patients ...

An expert discusses how non-muscle invasive bladder cancer (NMIBC) is a localized form of urothelial cell carcinoma that primarily affects older men with smoking as the primary risk factor, requiring ...

We’ll be back on Monday morning with more fresh content!

Papzimeos is the first and only FDA-approved treatment for adults with recurrent respiratory papillomatosis (RRP), with ...

To help Medicare plans better manage members with high drug expenses, Prime Therapeutics has launched an AI-driven tool to ...

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive (MHE) editorial advisory board, is host of the ...

Those with hemophilia face heightened risks of depression and anxiety due to pain and joint issues, impacting their overall ...

IO Biotech plans to meet with the FDA this fall to discuss the data from the phase 3 trial of Cylembio and determine next ...

Dupixent shows potential as a treatment for atopic dermatitis, alopecia and vitiligo, targeting shared immune pathways for ...

According to the American Cancer Society, about 22,000 new esophageal cancer cases were diagnosed in 2025 in the U.S., and ...